Rapid global characterization of immunoglobulin G1 following oxidative stress

References

• Harris M. Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol. 2004;5:292–302. doi:10.1016/S1470-2045(04)01467-6.
   PubMed Web of Science ®Google Scholar
• Reichert JM. Monoclonal antibodies as innovative therapeutics. Curr Pharm Biotechnol. 2008;9:423–30. doi:10.2174/138920108786786358.
   PubMed Web of Science ®Google Scholar
• Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol. 2010;10:301–16. doi:10.1038/nri2761.
   PubMed Web of Science ®Google Scholar
• Wang W, Ignatius AA, Thakkar SV. Impact of residual impurities and contaminants on protein stability. J Pharm Sci. 2014;103:1315–30. doi:10.1002/jps.23931.
   PubMed Web of Science ®Google Scholar
• Gaza-Bulseco G, Faldu S, Hurkmans K, Chumsae C, Liu H. Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;870:55–62. doi:10.1016/j.jchromb.2008.05.045.
   PubMed Web of Science ®Google Scholar
• Li S, Nguyen TH, Schöneich C, Borchardt RT. Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry. 1995;34:5762–72. doi:10.1021/bi00017a008.
   PubMed Web of Science ®Google Scholar
• Khossravi M, Shire SJ, Borchardt RT. Evidence for the involvement of histidine A(12) in the aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry. 2000;39:5876–85. doi:10.1021/bi9924720.
   PubMed Web of Science ®Google Scholar
• Luo Q, Joubert MK, Stevenson R, Ketchem RR, Narhi LO, Wypych J. Chemical modifications in therapeutic protein aggregates generated under different stress conditions. J Biol Chem. 2011;286:25134–44. doi:10.1074/jbc.M110.160440.
   PubMed Web of Science ®Google Scholar
• Wang W, Vlasak J, Li Y, Pristatsky P, Fang Y, Pittman T, Roman J, Wang Y, Prueksaritanont T, Ionescu R, et al. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies. Mol Immunol. 2011;48:860–66. doi:10.1016/j.molimm.2010.12.009.
   PubMed Web of Science ®Google Scholar
• Wei Z, Feng J, Lin HY, Mullapudi S, Bishop E, Tous GI, Casas-Finet J, Hakki F, Strouse R, Schenerman MA, et al. Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus. Anal Chem. 2007;79:2797–805. doi:10.1021/ac062311j.
   PubMed Web of Science ®Google Scholar
• Deperalta G, Alvarez M, Bechtel C, Dong K, McDonald R, Ling V. Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting. MAbs. 2013;5:86–101. doi:10.4161/mabs.22965.
   PubMed Web of Science ®Google Scholar
• Xu G, Chance MR. Radiolytic modification of sulfur-containing amino acid residues in model peptides: fundamental studies for protein footprinting. Anal Chem. 2005;77:2437–49. doi:10.1021/ac0484629.
   PubMed Web of Science ®Google Scholar
• Kumar S, Zhou S, Singh SK. Metal ion leachates and the physico-chemical stability of biotherapeutic drug products. Curr Pharm Des. 2014;20:1173–81. doi:10.2174/13816128113199990063.
   PubMed Web of Science ®Google Scholar
• Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem. 1993;62:797–821. doi:10.1146/annurev.bi.62.070193.004053.
   PubMed Web of Science ®Google Scholar
• Stadtman ER, Levine RL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids. 2003;25:207–18. doi:10.1007/s00726-003-0011-2.
   PubMed Web of Science ®Google Scholar
• Plowman JE, Deb-Choudhury S, Grosvenor AJ, Dyer JM. Protein oxidation: identification and utilisation of molecular markers to differentiate singlet oxygen and hydroxyl radical-mediated oxidative pathways. Photochem Photobiol Sci. 2013;12:1960–67. doi:10.1039/c3pp50182e.
   PubMed Web of Science ®Google Scholar
• Perdivara I, Deterding LJ, Przybylski M, Tomer KB. Mass spectrometric identification of oxidative modifications of tryptophan residues in proteins: chemical artifact or post-translational modification? J Am Soc Mass Spectrom. 2010;21:1114–17. doi:10.1016/j.jasms.2010.02.016.
   PubMed Web of Science ®Google Scholar
• Jefferis R. Posttranslational modifications and the immunogenicity of biotherapeutics. J Immunol Res. 2016;2016:5358272. doi:10.1155/2016/5358272.
   PubMed Web of Science ®Google Scholar
• Xu G, Chance MR. Radiolytic modification and reactivity of amino acid residues serving as structural probes for protein footprinting. Anal Chem. 2005;77:4549–55.
   PubMed Web of Science ®Google Scholar
• Zhang H, Shen W, Rempel D, Monsey J, Vidavsky I, Gross ML, Bose, R., et al. Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase. Mol Cell Proteomics. 2011;10:M110.005678. doi:10.1074/mcp.M110.005678.
   Web of Science ®Google Scholar
• Charvátová O, Foley BL, Bern MW, Sharp JS, Orlando R, Woods RJ. Quantifying protein interface footprinting by hydroxyl radical oxidation and molecular dynamics simulation: application to galectin-1. J Am Soc Mass Spectrom. 2008;19:1692–705. doi:10.1016/j.jasms.2008.02.014.
   PubMed Web of Science ®Google Scholar
• Collier TS, Diraviyam K, Monsey J, Shen W, Sept D, Bose R. Carboxyl group footprinting mass spectrometry and molecular dynamics identify key interactions in the HER2-HER3 receptor tyrosine kinase interface. J Biol Chem. 2013;288:25254–64. doi:10.1074/jbc.M113.474882.
   PubMed Web of Science ®Google Scholar
• Nowak CK, Cheung JM, Dellatore S, Katiyar A, Bhat R, Sun J, Ponniah G, Neill A, Mason B, Beck A, et al. Forced degradation of recombinant monoclonal antibodies: A practical guide. MAbs. 2017;9:1217–30. doi:10.1080/19420862.2017.1368602.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li X, Liu YH, Richardson D, Li H, Shameem M, et al. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion. MAbs. 2016;8:1477–86. doi:10.1080/19420862.2016.1196521.
   PubMed Web of Science ®Google Scholar
• Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, Meng, Y G., Mulkerrin, M G., et al. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol. 2000;164:4178–84. doi:10.4049/jimmunol.164.8.4178.
   PubMed Web of Science ®Google Scholar
• Thommesen JE, Michaelsen TE, Løset G, Sandlie I, Brekke OH. Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation. Mol Immunol. 2000;37:995–1004. doi:10.1016/S0161-5890(01)00010-4.
   PubMed Web of Science ®Google Scholar
• Bertolotti-Ciarlet A, Wang W, Lownes R, Pristatsky P, Fang Y, McKelvey T, et al. Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors. Mol Immunol. 2009;46:1878–82. doi:10.1016/j.molimm.2008.12.022.
   PubMed Web of Science ®Google Scholar
• Pan H, Chen K, Chu L, Kinderman F, Apostol I, Huang G. Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Sci. 2009;18:424–33. doi:10.1002/pro.24.
   PubMed Web of Science ®Google Scholar
• Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, et al. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem. 2001;276:6591–604. doi:10.1074/jbc.M009483200.
   PubMed Web of Science ®Google Scholar
• Martin WL, West AP, Gan L, Bjorkman PJ. Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol Cell. 2001;7:867–77.
   PubMed Web of Science ®Google Scholar
• Zhou S, Evans B, Schöneich C, Singh SK. Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments. AAPS PharmSciTech. 2012;13:284–94. doi:10.1208/s12249-011-9747-2.
   PubMed Web of Science ®Google Scholar
• MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26:966–68. doi:10.1093/bioinformatics/btq054.
   PubMed Web of Science ®Google Scholar
• Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem. 1991;266:2005–08.
   PubMed Web of Science ®Google Scholar
• Schroeder HW, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125:S41–52. doi:10.1016/j.jaci.2009.09.046.
   PubMed Web of Science ®Google Scholar
• Sondermann P, Huber R, Oosthuizen V, Jacob U. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature. 2000;406:267–73.
   PubMed Web of Science ®Google Scholar
• Moore GL, Chen H, Karki S, Lazar GA. Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions. MAbs. 2010;2:181–89. doi:10.4161/mabs.2.5.13089.
   PubMed Web of Science ®Google Scholar
• Sauer-Eriksson AE, Kleywegt GJ, Uhlén M, Jones TA. Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. Structure. 1995;3:265–78. doi:10.1016/S0969-2126(01)00157-5.
   PubMed Web of Science ®Google Scholar
• Tsiatsiani L, Heck AJ. Proteomics beyond trypsin. Febs J. 2015;282:2612–26. doi:10.1111/febs.13287.
   PubMed Web of Science ®Google Scholar
• van der Post S, Thomsson KA, Hansson GC. Multiple enzyme approach for the characterization of glycan modifications on the C-terminus of the intestinal MUC2mucin. J Proteome Res. 2014;13:6013–23. doi:10.1021/pr500874f.
   PubMed Web of Science ®Google Scholar
• Chiva C, Ortega M, Sabidó E. Influence of the digestion technique, protease, and missed cleavage peptides in protein quantitation. J Proteome Res. 2014;13:3979–86. doi:10.1021/pr500294d.
   PubMed Web of Science ®Google Scholar
• Biringer RG, Amato H, Harrington MG, Fonteh AN, Riggins JN, Hühmer AF. Enhanced sequence coverage of proteins in human cerebrospinal fluid using multiple enzymatic digestion and linear ion trap LC-MS/MS. Brief Funct Genomic Proteomic. 2006;5:144–53. doi:10.1093/bfgp/ell026.
   PubMedGoogle Scholar